NA

NewEdge Advisors Portfolio holdings

AUM $19.4B
1-Year Return 18.33%
This Quarter Return
+10.75%
1 Year Return
+18.33%
3 Year Return
+66.44%
5 Year Return
+121.13%
10 Year Return
+255.56%
AUM
$19.4B
AUM Growth
+$2.56B
Cap. Flow
+$988M
Cap. Flow %
5.09%
Top 10 Hldgs %
18.4%
Holding
4,203
New
246
Increased
1,651
Reduced
1,243
Closed
216

Sector Composition

1 Technology 14.97%
2 Financials 7%
3 Consumer Discretionary 4.43%
4 Healthcare 3.72%
5 Communication Services 3.37%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OTLY
3951
Oatly Group
OTLY
$524M
$24 ﹤0.01%
2
TZA icon
3952
Direxion Daily Small Cap Bear 3x Shares
TZA
$287M
$24 ﹤0.01%
2
BEEM icon
3953
Beam Global
BEEM
$44.7M
$23 ﹤0.01%
16
MNTS icon
3954
Momentus
MNTS
$14M
$22 ﹤0.01%
18
MYPSW icon
3955
PLAYSTUDIOS, Inc. Warrant
MYPSW
$21 ﹤0.01%
1,667
SDGR icon
3956
Schrodinger
SDGR
$1.41B
$20 ﹤0.01%
1
TTSH icon
3957
Tile Shop Holdings
TTSH
$278M
$19 ﹤0.01%
3
SUUN
3958
PowerBank Corporation Common Stock
SUUN
$71.4M
$17 ﹤0.01%
11
GORV icon
3959
Lazydays
GORV
$10.6M
$16 ﹤0.01%
2
IVR icon
3960
Invesco Mortgage Capital
IVR
$529M
$16 ﹤0.01%
2
QVCGA
3961
QVC Group, Inc. Series A Common Stock
QVCGA
$73.3M
$14 ﹤0.01%
5
-1
-17% -$3
BRAG
3962
Bragg Gaming Group
BRAG
$68M
$13 ﹤0.01%
3
-2
-40% -$9
MRAM icon
3963
Everspin Technologies
MRAM
$147M
$13 ﹤0.01%
2
FCA icon
3964
First Trust China AlphaDEX Fund
FCA
$58.6M
$12 ﹤0.01%
1
MURA icon
3965
Mural Oncology
MURA
$35.9M
$12 ﹤0.01%
5
-10
-67% -$24
LCUT icon
3966
Lifetime Brands
LCUT
$97.2M
$11 ﹤0.01%
2
TROX icon
3967
Tronox
TROX
$710M
$10 ﹤0.01%
2
-5
-71% -$25
XXII
3968
22nd Century Group
XXII
$6.47M
$8 ﹤0.01%
+1
New +$8
TONX
3969
TON Strategy Company Common Stock
TONX
$648M
$7 ﹤0.01%
1
ABEO icon
3970
Abeona Therapeutics
ABEO
$353M
$6 ﹤0.01%
1
EVF
3971
Eaton Vance Senior Income Trust
EVF
$101M
$6 ﹤0.01%
1
BKYI
3972
BIO-key International
BKYI
$5.16M
$3 ﹤0.01%
4
DXLG icon
3973
Destination XL Group
DXLG
$66.8M
$2 ﹤0.01%
2
NVVE icon
3974
Nuvve Holding Corp
NVVE
$4.21M
$2 ﹤0.01%
2
PMCB icon
3975
PharmaCyte Biotech
PMCB
$6.46M
$2 ﹤0.01%
2